Read more about our current projects partnering with leading clinicians, institutions and academics across the UK.

NICE has approved the use of the drug fruquintinib (Fruzaqla) for eligible advanced bowel cancer patients living in England and Wales.

The Government has published its 10 Year Health Plan, following a consultation to shape the future of the NHS in England.